← back to database
Red Tree backs early-stage life science entrepreneurs developing first-in-class and best-in-class therapeutics. The firm is West Coast–centric and focuses on oncology, neurology, and immunology. It leverages deep relationships with leading academic and research institutions to access scientists and entrepreneurs. As a life science venture capital firm, it partners with founders to translate scientific innovation into viable therapies.
Primary stage
Lead / follow
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Heath LukatchCo-Founder and Managing Partner
- Jeremy CaldwellManaging Director